MCRC
Clinical trials for MCRC explained in plain language.
Never miss a new study
Get alerted when new MCRC trials appear
Sign up with your email to follow new studies for MCRC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Virus joins fight against stubborn colon cancer
Disease control Not yet recruitingThis study is testing whether adding an experimental virus therapy called pelareorep to standard chemotherapy drugs (FOLFIRI + bevacizumab) works better for people with advanced colorectal cancer that has spread and stopped responding to their first treatment. About 60 participan…
Matched conditions: MCRC
Phase: PHASE2 • Sponsor: Oncolytics Biotech • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New two-drug attack on spreading colon cancer enters testing
Disease control Not yet recruitingThis study is testing if a new drug called SHR-1811, when combined with an existing drug (bevacizumab), can help control advanced colorectal cancer that has spread and worsened after standard first treatment. It will involve about 80 adults whose cancer has a certain level of a p…
Matched conditions: MCRC
Phase: PHASE2 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC